Stephen Archer

Dr. Stephen Archer is a Professor and former Head of the Department of Medicine at Queen's University. He holds the C. Franklin and Helene K. Bracken Chair and serves as Director of the Translational Institute of Medicine (TIME) and Scientific Director of the Queen’s CardioPulmonary Unit (QCPU). His expertise spans pulmonary hypertension, mitochondrial biology, and translational cardiovascular research. Dr. Archer has over 300 publications, an H-index of 113, and >50,000 citations.

Education:

• MD from Queen’s University (1981)
• Bachelor of Arts from Queen’s University (1977)

Research Interests:

• Pulmonary arterial hypertension mechanisms and therapies
• Oxygen sensing via mitochondrial pathways
• Right ventricular dysfunction
• Experimental therapeutics for cancer

Key Contributions:

• Founded the QCPU, an $8M translational research facility
• Co-founded TIME at Queen’s University
• Developed mitochondrial fission inhibitors like Drpitor1a

Awards:

• Fellow of the Royal Society of Canada
• Distinguished Scientist Awards (AHA, ACC)
• AFMC President’s Award (2023)

Grants & Mentorship:

• CIHR-funded research lab
• Mentored over 75 trainees

Labs/Teams: Leads the Archer Lab at Queen’s University, focusing on mitochondrial dynamics and oxygen-sensing pathways.